Skip to content

Predict the rehabilitation status of patients wit'h severe intracerebral hemorrhage three months later using intelligent algorithms.

Construction and Multicenter Validation of a Machine Learning-Based Prediction Model for the 90-Day Functional Prognosis of Patients with Severe Intracerebral Hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101676
Enrollment
Unknown
Registered
2025-04-28
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specific diseases: 1. Hypertensive intracerebral hemorrhage 2. Rupture and bleeding of cerebral aneurysm 3. Hemorrhage due to cerebral vascular malformation 4. Others: Including cerebral amyloid angiopathy, hematological diseases (such as leukemia, thrombocytopenic purpura, etc.), hemorrhage after infarction, cerebral arteritis, hemorrhage after anticoagulant or thrombolytic therapy, etc. S

Interventions

The group with good prognosis and the group with poor prognosis:None

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Severe patients diagnosed with spontaneous intracerebral hemorrhage and having a Glasgow Coma Scale (GCS) score of <= 8 upon admission to the hospital; 2.Admitted to the Neuro-intensive Care Unit (NICU) and received standardized treatment and nursing care; 3.Complete imaging examinations (CT, MRI) and basic laboratory tests within 24 hours after admission to the hospital; 4.Have complete nursing records, including information on interventions such as the frequency of basic nursing operations, sedation and analgesia strategies, nutritional support, oral cavity care, and body position management.

Exclusion criteria

Exclusion criteria: 1.Have other serious diseases that affect the independence of prognosis, such as severe heart, liver, and kidney failure, or advanced malignant tumors; 2.Patients who had a history of severe neurological deficits or long-term severe dependence (Modified Rankin Scale (mRS) >= 4) and for whom the functional changes caused by this hemorrhage could not be clearly determined; 3.Cases with incomplete data or for which follow-up data (90-day mRS score) could not be obtained;

Design outcomes

Primary

MeasureTime frame
The mRS score at 90 days;

Countries

China

Contacts

Public ContactPengju Wang

The First Hospital of Jilin University

wangpengju87@jlu.edu.cn+86 431 88783351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026